Eurofins Scientific SE (ERFSF) Stock

About Eurofins Scientific SE

Eurofins Scientific SE, along with its affiliated companies, delivers a broad spectrum of analytical testing and laboratory solutions globally. The firm utilizes an extensive repertoire of approximately 200,000 analytical techniques, designed to assess various product attributes such as safety, identification, makeup, genuineness, source, trackability, and cleanliness. Its offerings span numerous sectors. These include agro-science, encompassing biological evaluations, consumer, human, and environmental safety assessments, product chemical analysis, regulatory guidance, and seed services. The company also handles general agro testing. Its assurance division provides product inspections, audits, certifications, training, and advisory services for items across food, consumer goods, healthcare, and cosmetics industries. Other specialized areas are biopharma and clinical diagnostics. Furthermore, Eurofins conducts comprehensive consumer product testing, covering compliance, audits, examinations, certifications, inspections, training programs, and digital media and cybersecurity solutions for a diverse range of sectors. It also specializes in cosmetics and personal care product analysis, and environmental testing for substances like water, air, soil, waste, and other materials. Food and feed testing is another key segment, addressing concerns such as allergens, GMOs, grain quality, meat composition, nanomaterials, pesticides, and residual DNA. The company's extensive food-related portfolio also includes audit and certification services, authenticity verification, carbohydrate analysis, consulting, detection of dioxins and persistent organic pollutants (POPs), food irradiation checks, labeling compliance, legal guidance, heavy metal screening, identity preservation, mealtime analysis, molecular and microbiology testing, mycotoxin detection, nutritional profiling, organic contaminant analysis, packaging and migration studies, radioactivity testing, rapid testing methods, sensory and consumer research, various training initiatives, veterinary drug residue screening, and vitamin content analysis. Beyond these, Eurofins offers expertise in forensic science, genomics, maritime applications, materials and engineering, REACH compliance, and advanced technologies. The company maintains a significant global presence, operating roughly 900 laboratories across 54 nations. Established in 1987, its main office is situated in Luxembourg City, Luxembourg.

Eurofins Scientific SE is headquartered in LU.

Eurofins Scientific SE (ERFSF) stock trades at $81.74 with a market capitalization of $14.14B. The stock is valued at a price-to-earnings (P/E) ratio of 27.93, price-to-book of 3.52, price-to-sales of 1.64. Over the past 52 weeks the stock has ranged between $64.95 and $86.20, and currently trades 5.2% below its 52-week high. It pays a dividend yielding 1.03%.

On profitability, Eurofins Scientific SE generates a return on equity (ROE) of 11.62%, return on capital employed of 13.32%, an operating margin of 15.62%, a net profit margin of 6.51%.

Official website: www.eurofins.com

Eurofins Scientific SE by the numbers, 2016–2025

Between 2016 and 2025 Eurofins Scientific SE reported revenue of $2.5B rising to $7.3B, a change of +187.5% across 10 years. Compounded, revenue has grown 6.0% a year over five years, 2.8% over three, 4.9% over the last twelve months. Net profit rose to $475.0M.

Operating margin went from 11.1% in 2016 to 11.2% in 2025, essentially unchanged. The most recent net margin is 6.51%. On a trailing twelve-month basis to Dec '25, revenue is $14.2B and net profit $882.0M.

Borrowings rose from $1.4B to $4.4B, cash on hand is $790.7M, cash from operations was $1.3B in the latest year, positive in 10 of the last 10.

Return on equity has averaged 11.3% over five years, and was 13.4% in the most recent year.

The share price itself has compounded at -6.8% a year over five years, 5.3% over three, 10.2% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

Eurofins Scientific SE (ERFSF) — frequently asked questions